Our team contributed to one of the largest pediatric thyroid cancer datasets to date, helping uncover unique molecular markers associated with aggressive histologic behavior in differentiated thyroid cancer. This work provides critical insights into risk stratification for younger patients and underscores the importance of genomics in guiding pediatric oncologic care (PMID: 34915753).